Back to the directory
Darmiyan
Early detection of Alzheimer's disease
- Status
- Active
- Stage
- Early
- Team size
- 8
- Location
- San Francisco, CA, USA
- Category
- Medical Devices & Diagnostics
- Sector
- Diagnostics
About Darmiyan
Novel quantitative virtual microscopy for early detection of Alzheimer's disease from non-invasive MRI.
Artificial IntelligenceDiagnosticsHealth TechMachine Learning
FDA clearances
1 510(k) clearance on record, 2024.
- BrainSee
DEN220066
Source: FDA 510(k) database via openFDA.
Securities filings
2 Form D filings on record, 2020 to 2023.
Filed as Darmiyan, Inc.
Source: SEC EDGAR. Form D reports an exempt offering; it does not confirm funds raised.
Company data compiled and maintained by Healthcare Discovery.
